H. Acha-Orbea/H. MacDonald: Superantigens of mouse mammary tumor virus. Ann. Rev. Imm. 13 (1995), 459-... 15208 Andre' Ahr a.o.: Identification of high risk breast-cancer patients by gene expression profiling. Lancet 12 January 2002, 131-132. 20356 Gabriela Alexe/.../Peter Hammer: Breast cancer prognosis by combinatorial analysis of gene expression data. Breast Cancer Res. 8 (2006), 20p. 19500 Minna Allinen/.../Kornelia Polyak: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6 (2004), 17-32. 10426 Sarah Anzick a.o.: AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 15 August 1997, 965-968. Irvin Ariel/Anthony Cahan (ed.): Treatment of pre-cancerous lesions and early breast cancer. 16117 Subhash Bagui/Sikha Bagui/Kuhu Pal/Nikhil Pal: Breast cancer detection using rank nearest neighbor classification rules. Pattern Recognition 36 (2003), 25-34. 14429 C. Bajdik a.o.: A computer model to simulate family history of breast/ovarian cancer in BRCA1 mutation carriers. Math. Biosci. 171 (2001), 99-111. 20061 Nicholas Bakalar: Tumor types may explain survival rates for cancer. New York Times 24 October 2006, 1p. 19745 Stuart Baker/Paul Lichtenstein/Jaakko Kaprio/Niels Holm: Genetic susceptibility to prostate, breast, and colorectal cancer among nordic twins. Biometrics 61 (2005), 55-63. 21450 Armand Bankhead/Robert Heckendorn: Using evolvable genetic cellular automata to model breast cancer. Gen. Programm. Evolv. Mach. 8 (2007), 381-393. Rita Baron-Faust: Breast cancer. What every woman should know. "The author is a medical journalist and had numerous breast cancer authorities review her text before it was published. The information is as up to date as is possible for a publication date of 1995. There are brief quotations from cancer patients that illustrate points throughout the book. This helps to overcome the somewhat detached manner in which the material is presented. There is an excellent list of resources, further reading and an index included in this volume." (F. Beslanwitch) 20506 Deena Beasley: Breast cancer vaccine may reduce risk of death. Internet 2008, 2p. 19523 Sarah Behrens/.../Heinz-Otto Peitgen: Computer assistance for MR based diagnosis of breast cancer - present and future challenges. Comp. Med. Imag. Graphics 31 (2007), 236-247. D. Black/E. Solomon: The search for the familial breast/ovarian cancer gene. Trends. Genet. 9 (1993), 22-26. 21108 David Blokh/.../Mordechai Deutsch: Breast cancer detection by Michaelis-Menten constants via linear programming. Com. Meth. Progr. Biomed. 85/3 (2007), 210-213. 19451 Gianni Bonadonna/.../Pinuccia Valagusa: Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and fluorouracil in operable breast cancer. J. Clin. Onc. 22/9 (2004), 1614-1620. 20575 Peter Bouwman/Jos Jonkers: Mouse models for BRCA1 associated tumorigenesis. Cell Cycle 1 September 2008, 2647-2653. Anne Bowcock: Breast cancer. Humana Press 1998. 0-89603560-3. $125. 5401 Phyllida Brown: Breast cancer finding sparks insurance fears. New Scientist 28 August 1993, 8. Health reforms in the US must prevent the insurance industry from taking an individual's genetic susceptibility to disease into account when calculating premiums. A gene, calle BRCA1, is thought to cause about half of all cases in which the disease is inherited. At least one in 12 women in Britain will develop breast cancer in their lifetime. Once tests for BRCA1 are developed, women will face a dilemma about whether or not to be tested. I. Campbell a.o.: A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1. Hum. Mol. Genet. 3 (1994), 589-594. Gilda Cardenosa: Breast imaging companion. Lippincott-Raven 1997. 0-39751778-5. 9597 Luigi Castagnetta/Italo Nenci/H. Leon Bradlow (ed.): Basis for cancer management. NYAS 1996. P. Chappuis a.o.: Prognostic significance of p53 mutation in breast cancer - frequent detection of non-missense mutations by yeast functional assay. Int. J. Cancer 84 (1999), 587-593. Wendy Chen/Andrew Wardley/Arthur Skarin (ed.): Breast cancer. Mosby 2007, 180p. Eur 37. Theodosia Choreutaki/Francesca Scarpellini/Vincenzo Eusebi: Breast cancer necrosis following fine needle aspiration biopsy. Tumori 82/3 (1996), ... 19363 Susan Clare/Faina Nakhlis/John Carl Panetta: Molecular biology of breast cancer metastasis - the use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer. Breast Cancer Res. 2 (2000), 430-435. 15581 Donald Coffey: Similarities of prostate and breast cancer - evolution, diet, and estrogens. Urology 57 (suppl. 4 A) April 2001, 31-38. Colditz a.o: Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 264/20 (1990), 2648-26543. 18393 H. Coppock/R. Clarke: Mammary stem cells - the root of breast cancer? Breast Cancer Online 7/9 (2004), 4p. 19390 Holger Dambeck: Kernspin viel treffsicherer als Röntgen. Spiegel Online 10. August 2007, 1p. 10166 Nancy Davidson: Birgt die Substitutionstherapi mit O''strogenen ein Krebsrisiko? In 10158 Hoefer, 44-45. 9082 Devra Lee Davis/H. Leon Bradlow: Verursachen Umwelto''strogene Brustkrebs? Spektrum 1995/12, 38-44. 9255 Guoren Deng a.o.: Loss of heterozygosity in normal tissues adjacent to breast carcinomas. Science 20 December 1996, 2057-2059. 18392 John Dick: Breast cancer stem cells revealed. Proc. Nat. Ac. Sci. USA 100/7 (2003), 3547-3549. 18487 Heiko Enderling/.../Jayant Vaidya: Mathematical modelling of radiotherapy strategies for early breast cancer. J. Theor. Biol. 241 (2006), 158-171. 19361 Heiko Enderling/.../Jayant Vaidya: A mathematical model of brest cancer development, local treatment and recurrence. J. Theor. Biol. 246 (2007), 245-259. Ron Falcone: Natural medicine for breast cancer. Dell 1997. 0-44022167-6. $6. 19547 Dietrich von Fournier/.../V. Barth: Growth rate of 147 mammary carcinomas. Cancer 45 (1980), 2198-2207. 16363 S. Franks/Helen Byrne/.../Claire Lewis: Modelling the early growth of ductal carcinoma in situ of the breast. J. Math. Biol. 47 (2003), 424-452. Vincent Friedewald/Arman Buzdar: Breast cancer. Andrews & McMeel 1997. 0-83622710-7. $9. 18422 Bernd Genser: Analyse palliativer Therapiesequenzen beim metastasierten Mammakarzinom unter Anwendung von Multi-State-Modellen. Diss. Univ. Graz 2002, 140p. 11966 W. Wayt Gibbs: Pra''vention von Brustkrebs. Spektrum 1998/7, 30-31. Raloxifen beugt wie Tamoxifen dem Brustkrebs vor und hat weniger Nebenwirkungen. 15459 Jill Graham a.o.: Stressful life experiences and risk of relapse of breast cancer - observational cohort study. BMJ 324 (202), ... Melvyn Greberman: Information systems in breast cancer detection. Hogrefe & Huber 1998. 0-88937036-2. $27. 21522 Matthew Grimshaw/.../Joy Burchell: Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res. 10 (2008), 10p. S. Gruvberger a.o.: Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61 (2001), 5979-5984. C. Haagenson: Diseases of the breast. 1986. 21531 Basim al-Hadidi/Muhammad Zubi/Hussam Suleiman: Mammogram breast cancer image detection using image processing functions. Inf. Techn. J. 6/2 (2007), 217-221. 21405 Michael Haffner/Chiara Berlato/Wolfgang Doppler: Exploiting our knowledge of NF-kappaB signaling for the treatment of mammary cancer. J. Mamm. Gland Biol. Neoplasia 11 (2006), 63-73. 18399 Muhammad al-Hajj/.../Michael Clarke: Prospective identification of tumorigenic breast cancer cells. Proc. Nat. Ac. Sci. USA 100 (2003), 3983-3988. Jay Harris/Mark Lippman/Monica Morrow/Samuel Hellman (ed.): Diseases of the breast. Lippincott-Raven 1996, 1080p. 0-397-51470-0. $190. 15697 Ingrid Hedenfalk a.o.: Gene-expression profiles in hereditary breast cancer. New England J. Med. 22 February 2001, 539-548. Henderson a.o.: Endogenous hormones as major factor in human cancer. Cancer Research 42 (1982), 3232-3239. Herbst a.o.: Effect of low fat, high carbohydrate diet on symptoms of cyclical mastopathy. Lancet 16 July 1971, 128-129. Charlotte Higgins-Lee: Surviving breast cancer. Dorrance 1997. 0-80594116-9. $7. 10158 Inge Hoefer (ed.): Krebsmedizin. Spektrum Spezial 5 (1997). 17568 Marilena Iorio/Manuela Ferracin/.../Massimo Negrini/Carlo Croce: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65/16 (2005), 7065-7070. 12614 V. Craig Jordan: Designer-O''strogene. Spektrum 1999/7, 66-73. 21397 Madhuri Kakarala/.../Max Wicha: Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res. Treat. ... (2009), 9p. John Kavanagh: Cancer in women. Blackwell 1998. 0-86542465-9. P. Kelly: Understanding breast cancer risk. Temple UP. 0-87722-813-2. $23. D. Kelsell/D. Black/D. Bishop/W. Spurr: Genetic analysis of the BRCA1 region in a large breast/ovarian family - refinement of the minimal region containing BRCA1. Hum. Mol. Gen. 2 (1993), 1823-1828. 8974 Jennifer Kelsey: The epidemiology of breast cancer. CA 41 (1991), 146-165. C. King/M. Kraus/S. Aaronsen: Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 252 (1985), 554-... Susan Elizabeth King: Treadding the maze - an artist's journey through breast cancer. Chronicle Books 1997. 0-81181605-2. $18. 19578 Nancy Klauber-DeMore/.../William Gerald: Biological behavior of human breast cancer micrometastases. Clin. Cancer Res. 7/8 (2001), 2434-2439. 18470 Christoph Klein/Dieter Hölzel: Systemic cancer progression and tumor dormancy. Mathematical models meet single cell genomics. Cell Cycle 5/16 (2006), 1788-1798. E. Kodish a.o.: Genetic testing for cancer risk. How to reconcile the conflicts. JAMA 279 (1998), 179-181. 20352 Harry de Koning/Gerrit Draisma/Jacques Fracheboud/Arry de Bruijn: Microsimulation modelling estimates based on observed screen and clinical data. Breast Cancer Res. 8 (2006), 5p. 19496 Charlotte Kuperwasser/.../Robert Weinberg: Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Nat. Ac. Sci. USA 101 (2004), 4966-4971. 21411 Manuela Labbozzetta/.../Natale D'Alessandro: Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer. Ann. NY Ac. Sci. Feb 2009, 278-283. 19437 Marc Lacroix/Robert-Alain Toillon/Guy Leclerq: Stable portrait of breast tumors during progression - data from biology, pathology and genetics. Endocr.-Rel. Cancer 11 (2004), 497-522. 19438 Marc Lacroix/Robert-Alain Toillon/Guy Leclerq: p53 and breast cancer, an update. Endocr.-Rel. Cancer 13 (2006), 293-325. 17340 Vladimir Lange: Be a survivor. Your guide to breast cancer treatment. Lange 2005, 180p. and DVD. $17. 16116 B. Lattimore/M. Crabbe: Expression profiles in the progression of ductal carcinoma of the breast. Comput. Biol. Chem. 27 (2003), 115-120. Susan Love: Breast Book. Addison-Wesley 1990. 9142 Donald Malins/Nayak Polissar/Sandra Gunselman: Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc. Nat. Ac. Sci. USA 93/6 (1996), 2557-2563. 20495 Olvi Mangasarian/W. Street/William Wolberg: Breast cancer diagnosis and prognosis via linear programming. Internet 1994, 9p. Douglas Marchant: Breast disease. Saunders 1997. 0-72166429-6. R. Mariani-Costantini a.o.: In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res. 48 (1988), 199-205. 19929 Paola Marignani: LKB1, the multitasking tumour suppressor kinase. J. Clin. Pathol. 58 (2005), 15-19. 10141 Jean Marx: Possible function found for breast cancer genes. Science 25 April 1997, 531-532. Massachusetts General Hospital: Breast cancer : The most comprehensive, up-to-date information available to help you understand your conditon, make the right treatment choices ... Times Books 1997. 0-81292321-9. $14. 14514 Alessandro Mazzucchelli: Prevenire il rischio con il "Pap test" della mammella. Fondamentale gennaio 2001, 10-11. W. McGuire a.o.: How to use prognostic factors in axillary node-negative breast cancer patients. J. NCI 82/12 (1990), 1006-1015. Y. Miki a.o.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994), 66-71. 16379 Jonathan Milner/Bruce Ponder/.../Tony Kouzarides: Transcriptional activation functions in BRCA2. Nature 24 April 1997, 772-773. Elisabeth Müller-Holzner: Morphologische Untersuchungen zur Hormon- abhängigkeit von Geweben unter besonderer Berücksichtigung des Mammakarzinoms. Habilitationsschrift Innsbruck, 1997. 19537 NCI: Cancer stat fact sheet - Cancer of the breast. NCI SEER 2007, 2p. 21144 Yuri Nikolsky/.../Kornelia Polyak: Genome-wide functional synergy between amplified and mutated genes in human breast cancer. Cancer Res. 68/22 (2008), 9532-9540. 19497 Larry Norton: Theoretical concepts and the emerging role of taxanes in adjuvant therapy. Oncologist 6 (2001), 30-35. 19364 Larry Norton: Edited comments. BCU 1 (2003), 4p. 19439 Larry Norton: Conceptual and practical implications of breast tissue geometry - toward a more effective, less toxic therapy. Oncologist 10 (2005), 370-381. R. Nusse: Insertional mutagenesis in mouse mammary tumorigenesis. Curr. Top. Microbiol. Imm. 171 (1991), 44-... C. O'Brian/V. Vogal/S. Singletary/N. Ward: Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res. 49 (1989), 3215-... O. Olopade: Genetics in clinical cancer care - the future is now. New England J. Med. 335 (1996), 1445-1456. Olson: History of breast cancer. Free 1997. 0-68482806-5. $25. C. Perou/T. Sorlie/M. Eisen a.o.: Molecular portraits of human breast tumours. Nature 406 (2000), 747-752. 8975 David Plotkin: Good news and bad news about breast cancer. Atlantic Monthly June 1996, 53-82. C. Pucillo/L. Palmer/R. Hodes: Superantigenic characteristics of mouse mammary tumor viruses play a critical role in susceptibility to infection in mice. Imm. Res. 14 (1995), 58-... 19499 Rangaraj Rangayyan/Thanh Nguyen: Fractal analysis of contours of breast masses in mammograms. J. Digital Imag. ... (2006), 1-15. 19431 Anne Regierer/Kurt Possinger: Mammakarzinom. Deutscher Ärzteverlag 2005, 140p. Eur 49. 19360 Michael Retsky: Cancer growth - implications for medicine and malpractice. Internet 1998, 4p. 19387 Michael Retsky/.../Pinuccia Valagussa: Computer simulation of a breast cancer metastasis model. Breast Cancer Res. Treat. 45 (1997), 193-202. 19411 Michael Retsky/.../Pinuccia Valagussa: Hypothesis - induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients. Breast Cancer Res. 6 (2004), 3p. 19579 Michael Retsky/.../Robert Wardwell: Recent translational research - computational studies of breast cancer. Breast Cancer Res. 7 (2005), 4p. 19498 Aylin Rizki/Mina Bissell: Homeostasis in the breast - it takes a village. Cancer Cell 6 (2004), 1-2. Rebecca Robinson/Jeanne Petrek: A step-by-step guide to dealing with your breast cancer. Citadel 1997. 0-80651763-8. $13. P. Rosen a.o.: Pathological prognostic factors in stage I (T1 N0 M0) and stage II (T1 N1 M0) breast carcinoma - a study of 644 patients with median follow-up of 18 years. J. Clin. Oncology 7/9 (1989), 1239-1251. Philip Rudland: Mammary development in cancer. Ashgate 1997. 1-85578087-9. $104. Vincenzo Russo a.o.: Expression of the MAGE gene family in primary and metastatic human breast cancer - implications for tumor antigen-specific immunotherapy. Int. J. Cancer 64/3 (1995), 216-221. 19776 Young Ryu/R. Chandrasekharan/Varghese Jacob: Breast cancer prediction using the isotonic separation technique. Europ. J. Op. Res. 181 (2007), 842-854. 19927 Kristine Scott/Suchita Nath-Sain/Meghan Agnew/Paola Marignani: LKB1 catalytically deficient mutants enhance cyclin D1 expression. Cancer Res. 67/12 (2007), 5622-5627. 11551 Robert Service: New role for estrogen in cancer? Science 279 (1998), 1631-1633. 16380 Shyam Sharan/Masami Morimatsu/.../Paul Hasty/Allan Bradley: Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 24 April 1997, 804-810. D. Shattuck-Eidens a.o.: BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA 278 (1997), 1242-1250. Lillie Shockney: Breast cancer survivor's club - a nurse's experience. Windsor House 1997. 1-88163610-0. $19. H. Sigurdsson a.o.: Indicators of prognosis in node-negative breast cancer. New England J. Med. 322/15 (1990), 1045-1053. D. Slamon a.o.: Human breast cancer - correlation of relapse and survival with amplification of the HER-2/Neu oncogene. Science 235 (1987), 177-... D. Slamon a.o: Studies of the HER-2/neu protooncogene in a human breast and ovarian cancer. Science 244 (1989), 707-... T. Sorlie/C. Perou a.o.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Nat. Ac. Sci. USA 98 (2001), 10869-10874. 6994 Darcy Spicer/Malcom Pike: Hormonal manipulation to prevent breast cancer. Science & Medicine July/August, 58-67. 19548 John Spratt/Mary Lou Kaltenbach/John Spratt: Cytokinetic definition of acute and chronic breast cancer. Cancer Res. 37 (1977), 226-230. 19546 John Spratt/.../Ernst Weber: Decelerating growth and human breast cancer. Cancer 71/6 (1993), 2013-2019. 4943 Francesco Squartini: Storia naturale del cancro della mammella. 2 Le Scienze, 104-113. Karen Stabiner: To dance with the devil - the new war on breast cancer. Bantam Doubleday Dell 1997. 0-38531284-9. $26. T. Stewart/P. Pattingale/P. Leder: Spontaneous mammary adenocarcinomas in transgenic mice that carry and expess MTV/myc fusion genes. Cell 38 (1984), 627-... 19388 Charles Streuli: Review of the book "The molecular basis of breast cancer" by Jose' and Irma Russo. Breast Cancer Res. 6 (2004), 179-180. 19436 Ian Tomlinson: Mutations in normal breast tissue and breast tumours. Breast Cancer Res. 3 (2001), 299-303. 19495 Gabriela Torres Mejia/.../Isabel dos Santos Silva: Mammographic features and subsequent risk of breast cancer - a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies. Cancer Epidem. Biomarkers Prev. 14/5 (2005), 1052-1059. 18432 Melissa Troester/.../Charles Perou: Gene expression patterns associated with p53 status in breast cancer. BMC Cancer 6 (2006), 13p. 15709 Laura van 't Veer a.o.: Gene expression profiling predicts clinical outcome of breast cancer. Nature 31 January 2002, 530-536. 19362 Claire Verschraegen/.../Guy Storme: Modeling the effect of tumor size in early breast cancer. Ann. Surgery 241/2 (2005), 309-318. 15696 Marc van de Vijver a.o.: A gene-expression signature as a predictor of survival in breast cancer. New England J. Med. 19 December 2002, 1999-2009. 19539 Vincent Vinh-Hung/Richard Gordon: Quantitative target sizes for breast tumor detection prior to metastasis - a prerequisite to rational design of 4D scanners for breast screening. Technol. Cancer Res. Treatment 4/1 (2005), 11-21. 18391 Alison Waterworth: Introducing the concept of breast cancer stem cells. Breast Cancer Res. 6/1 (2004), 53-54. M. West a.o.: Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Nat. Ac. Sci. USA 98 (2001), 11462-11467. 20689 Paula Whittington/.../Wei-zen Wei: DNA vaccination controls Her-2+ tumors that are refractory to targeted therapies. Cancer Res. 68/18 (2008), 7502-7511. R. Wooster a.o.: Identification of the breast cancer susceptibility gene BRCA2. Nature 378 (1995), 789-... Vance Wright-Browne/Gabriel Hortohagyi: High-dose chemotherapy for breast cancer - twenty years later. Whom should we treat? and when? Tumori 82/3 (1996), ... 18433 Mina Yaar/.../Barbara Gilchrest: Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells. Breast Cancer Res. 9 (2007), 13p. 20758 Yuqing Zhang/.../Lynn Rosenberg: Use of nonsteroidal antiinflammatory drugs and risk of breast cancer - the case-control surveillance study revisited. Am. J. Epidemiology 162/2 (2005), 6p. 8955 ZZ: Breast cancer update. Internet, ca. 1995. 8843 ZZ. Mamma-ca. Internet, Univ. Freiburg i. Br. 1996, ca. 30p. 8844 ZZ. Schilddru''sen-ca. Internet, Univ. Freiburg i. Br. 1996, ca. 15p. 9076 ZZ: Brustkrebs-Fru''herkennung. O''st. Krebshilfe, Internet 1996. 9077 ZZ: Mammakarzinom. O''st. Krebshilfe, Internet 1996. 9078 ZZ: Informationen zum Thema Mammographie. O''st. Krebshilfe, Internet 1996. 9127 ZZ: Should women in their 40s have mammograms? Beatson, Internet 1996. 9154 ZZ: Weibliche Hormone und Krebs. O''st. Krebshilfe, Internet 1996. ZZ: Our gift of love - stories of breast cancer courage. Gibbs Smith 1997. 0-87905791-2. $15. 19416 ZZ: A snapshot of breast cancer. Internet NCI 2006, 2p. 19424 ZZ: Fractal theory to diagnose and treat breast cancer. Internet 2006, 1p. 19415 ZZ: Kritische Diskussion der Arbeit "Is breast cancer survival improving?" von Giordano/.../Hortobagyi. Internet Tumorregister München 2007, 9p. 19412 ZZ: Überleben C50 Mammakarzinom Frauen. Internet Tumorregister München 2007, 7p. 19413 ZZ: Basis-Statistiken C50 Mammakarzinom Frauen. Internet Tumorregister München 2007, 11p. 19414 ZZ: Spezielle Auswertungen C50 Mammakarzinom Frauen - Krankheitsbild. Internet Tumorregister München 2007, 12p. 19443 ZZ: List of notable breast cancer patients. Wikipedia 2007, 9p. 21396 ZZ: Spices halt growth of breast stem cells, study finds. Science Daily 8 December 2009, 2p. Curcumin and piperine.